Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Julia Whitefield, Featured By Influential Women, Defines A Truly Distinguished Career In Pediatric Emergency Medicine
EIN Presswire
NM, UNITED STATES, October 14, 2026 /EINPresswire.com/ -- A Distinguished Physician Combines Pediatric Emergency Care, Advocacy, Education, and Medical-Legal Expertise Albuquerque, New Mexico – With more than four decades of experience in...
Tris Pharma Earns 2026 Great Place To Work Certification™
GlobeNewswire, Inc.
MONMOUTH JUNCTION, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Tris Pharma, Inc. is proud to be Certified™ by Great Place To Work®. The prestigious award is based entirely on what current employees say about their experience working at Tris Pharma and...
Family Medicine Forum, Canada’s largest family medicine celebration, returns to Toronto this November
GlobeNewswire, Inc.
MISSISSAUGA, Ontario, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Family Medicine Forum (FMF) is back in Toronto, November 11th to 14th, for four days of learning, networking, and celebrating family medicine.
Prodeon Medical Announces First Commercial Case of the Urocross® Expander System
GlobeNewswire, Inc.
SAN JOSE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prodeon Medical, a medical device company advancing minimally invasive therapies for urologic disease, today announced the first commercial case using its Urocross® Expander System.
CISCRP and Oxford PharmaGenesis Collaborate to Advance Public Education and Strengthen Trust in Clinical Research
EIN Presswire
CISCRP teams up with leading, global HealthScience communications consultancy on community engagement programs.
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
GlobeNewswire, Inc.
AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will highlight its latest spine innovations at the 41st Annual North American Spine Society (NASS)...
Voice AI model built to accurately capture real multilingual medical conversations
GlobeNewswire, Inc.
CAMBRIDGE, United Kingdom, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Today, Speechmatics releases Oak, a medical speech recognition model built on new architecture.
AgencyBloc introduces AMS+ Annual Review for Medicare Advantage
GlobeNewswire, Inc.
CEDAR FALLS, Iowa, Oct. 14, 2026 (GLOBE NEWSWIRE) -- AgencyBloc today announced the public beta of AMS+ Annual Review, an AI-powered feature designed to help insurance agents identify changes to Medicare Advantage clients’ coverage and prepare for...
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
GlobeNewswire, Inc.
Differentiated, portable buccal film would offer patients and caregivers an alternative to existing nasal and rectal seizure rescue treatments, a market opportunity that exceeds $450 million annually in the U.S. Patient market research...
Orvida Pharma Announces FDA Acceptance of KM-023 (ontivatrep) into Rare Disease Evidence Principles Process for Olmsted Syndrome
GlobeNewswire, Inc.
FDA’s Rare Disease Evidence Principles (RDEP) process aims to provide greater speed and predictability in the review of therapies for rare diseases with significant unmet medical need Acceptance enables engagement with FDA on the data needed to...
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
GlobeNewswire, Inc.
New dose-ranging cohort in FAP builds on compelling early clinical evidence observed with zolucatetide in patients with FAP and concomitant desmoid tumors Zolucatetide directly inhibits β-catenin:TCF, targeting the APC-mutation biology that drives...
SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
GlobeNewswire, Inc.
Award recognizes Dr. Chung’s extraordinary career as an internationally known expert in burn critical care, combat casualty care, acute organ failure, and extracorporeal organ support Keynote presentation and award ceremony to occur at Update in...
Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems
GlobeNewswire, Inc.
First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales Increased 289% Reiterates Expectation of Flat to Modest Revenue Growth for FY 27 Reflecting Timing of Several...
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
GlobeNewswire, Inc.
– Company on track to initiate first-ever formal clinical trial in Peeling Skin Syndrome before year end – Orphan Drug designation milestone provides 10 years of market exclusivity for Peeling Skin Syndrome in Europe after receipt of marketing...
Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg
GlobeNewswire, Inc.
AVT29 submitted to the European Medicines Agency as a line extension to the existing marketing authorization for Mynzepli® (aflibercept 2 mg) High-dose aflibercept offers the potential to reduce treatment frequency for patients with retinal...
Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire, Inc.
Dr. O’Malley brings deep immunology clinical development expertise, with previous leadership roles at CRISPR Therapeutics and Sanofi Appointment follows Matchpoint’s recent $150M Series B financing to advance pipeline of first-in-class oral small...
Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
GlobeNewswire, Inc.
Establishes strategic commercial reach across the Middle East and North Africa, advancing Ocugen’s goal of enabling global patient access to potentially transformational gene therapies Expands access to a potential one-time gene therapy for...
Nxera Pharma Enters into Exclusive License, Supply and Commercialization Agreement with Synmosa for QUVIVIQ® (daridorexant) Across Eight Asia-Pacific Markets
GlobeNewswire, Inc.
Synmosa to lead regulatory approvals, market access, distribution and sales in Singapore, Thailand, Indonesia, Malaysia, the Philippines, Vietnam, Australia and New Zealand.
There’s no single career pathway through medicine
Royal College of Physicians
Today's training system was largely designed for a generation of doctors whose careers looked very different.
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx® Assay In Gynecologic Cancers
EIN Presswire
Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policy DataMeds AI, Inc. (NASDAQ:MEDS) TAMPA, FL, UNITED STATES, October 13, 2026 /EINPresswire.com/ -- DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI,” “DataMEDS SI,”...
Sign up for:
Today in Medicine
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.